These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 33963536

  • 21. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R, RENAL Replacement Therapy Study Investigators.
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [Abstract] [Full Text] [Related]

  • 22. Vancomycin dosing in high-intensity continuous renal replacement therapy: A retrospective cohort study.
    Srour N, Lopez C, Succar L, Nguyen P.
    Pharmacotherapy; 2023 Oct; 43(10):1015-1023. PubMed ID: 37458062
    [Abstract] [Full Text] [Related]

  • 23. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
    Jiang SP, Xu YY, Ping-Yang, Wu WF, Zhang XG, Lu XY, Xiao YH, Liang WF, Chen J.
    Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
    [Abstract] [Full Text] [Related]

  • 24. Vancomycin removal and pharmacokinetics during accelerated venovenous hemofiltration.
    Lopez ND, Griggs M, Sin JH, Roberts RJ, Allegretti AS.
    Pharmacotherapy; 2024 Jan; 44(1):69-76. PubMed ID: 37798109
    [Abstract] [Full Text] [Related]

  • 25. Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy.
    Wang C, Chen J, Yang B, Li S, Zhang Y, Chen L, Wang T, Dong Y.
    Pharmacotherapy; 2023 Mar; 43(3):180-188. PubMed ID: 36714991
    [Abstract] [Full Text] [Related]

  • 26. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Chaijamorn W, Jitsurong A, Wiwattanawongsa K, Wanakamanee U, Dandecha P.
    Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
    [Abstract] [Full Text] [Related]

  • 27. Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF).
    Kirwan M, Munshi R, O'Keeffe H, Judge C, Coyle M, Deasy E, Kelly YP, Lavin PJ, Donnelly M, D'Arcy DM.
    Crit Care; 2021 Dec 20; 25(1):443. PubMed ID: 34930430
    [Abstract] [Full Text] [Related]

  • 28. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
    Joseph K, Ramireddy K, Madison G, Turco T, Lui M.
    J Clin Pharm Ther; 2021 Aug 20; 46(4):1103-1108. PubMed ID: 33768555
    [Abstract] [Full Text] [Related]

  • 29. Aminoglycoside Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    Krueger CK, Bruno JJ, Tverdek FP, Hernandez M, Abudayyeh A.
    Ann Pharmacother; 2023 Jun 20; 57(6):629-636. PubMed ID: 36062536
    [Abstract] [Full Text] [Related]

  • 30. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS, Matzke GR, Frye RF, Palevsky PM.
    Am J Kidney Dis; 1998 Jun 20; 31(6):1019-27. PubMed ID: 9631848
    [Abstract] [Full Text] [Related]

  • 31. Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing.
    Bouman CS, van Kan HJ, Koopmans RP, Korevaar JC, Schultz MJ, Vroom MB.
    Intensive Care Med; 2006 Dec 20; 32(12):2013-9. PubMed ID: 17043848
    [Abstract] [Full Text] [Related]

  • 32. Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.
    Blot S, Koulenti D, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, Roberts JA.
    Crit Care; 2014 May 15; 18(3):R99. PubMed ID: 24887569
    [Abstract] [Full Text] [Related]

  • 33. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
    Garbez N, Mbatchi LC, Maseda E, Luque S, Grau S, Wallis SC, Muller L, Lipman J, Roberts JA, Lefrant JY, Roger C.
    Ther Drug Monit; 2021 Dec 01; 43(6):747-755. PubMed ID: 33560097
    [Abstract] [Full Text] [Related]

  • 34. Levetiracetam dosing in patients receiving continuous renal replacement therapy.
    Chaijamorn W, Charoensareerat T, Rungkitwattanakul D, Phunpon S, Sathienluckana T, Srisawat N, Pattharachayakul S.
    Epilepsia; 2021 Sep 01; 62(9):2151-2158. PubMed ID: 34247386
    [Abstract] [Full Text] [Related]

  • 35. Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study.
    Bakke V, Sporsem H, Von der Lippe E, Nordøy I, Lao Y, Nyrerød HC, Sandvik L, Hårvig KR, Bugge JF, Helset E.
    Acta Anaesthesiol Scand; 2017 Jul 01; 61(6):627-635. PubMed ID: 28444760
    [Abstract] [Full Text] [Related]

  • 36. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
    Hill DM, Velamuri SR, Lanfranco J, Romero Legro I, Sinclair SE, Hickerson WL.
    Burns; 2019 Mar 01; 45(2):423-432. PubMed ID: 30340863
    [Abstract] [Full Text] [Related]

  • 37. Individualized Pharmacokinetic Dosing of Vancomycin Reduces Time to Therapeutic Trough Concentrations in Critically Ill Patients.
    Truong J, Smith SR, Veillette JJ, Forland SC.
    J Clin Pharmacol; 2018 Sep 01; 58(9):1123-1130. PubMed ID: 29957824
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
    Kiser TH, Fish DN, Aquilante CL, Rower JE, Wempe MF, MacLaren R, Teitelbaum I.
    Crit Care; 2015 Feb 03; 19(1):32. PubMed ID: 25645660
    [Abstract] [Full Text] [Related]

  • 39. A prospective, real-world, clinical pharmacokinetic study to inform lacosamide dosing in critically ill patients undergoing continuous venovenous haemofiltration (PADRE-02).
    Kalaria SN, Armahizer M, McCarthy P, Badjatia N, Gobburu JV, Gopalakrishnan M.
    Br J Clin Pharmacol; 2021 Nov 03; 87(11):4375-4385. PubMed ID: 33855736
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of zanamivir in critically ill patients undergoing continuous venovenous hemofiltration.
    Wieringa A, Ter Horst PG, Wagenvoort GH, Koch BC, Haringman JJ.
    Antivir Ther; 2023 Feb 03; 28(1):13596535221150746. PubMed ID: 36609161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.